Literature DB >> 320924

Pulmonary aerosol deposition in chronic bronchitis: intermittent positive pressure breathing versus quiet breathing.

M B Dolovich, D Killian, R K Wolff, G Obminski, M T Newhouse.   

Abstract

Quiet breathing by mouth of a 3-mum aerosol was compared with intermittent positive pressure delivery of the same aerosol to the lung in a group of bronchitics. The pattern of lung deposition and the total dose delivered to the lung were measured. The differences between quiet breathing and intermittent positive pressure breathing were found not to be significant (P greater than 0.5). In addition, during similar or greater total ventilation, intermittent positive pressure breathing delivered a mean of 32% less aerosol to the lung than did quiet breathing. These findings suggest that intermittent positive pressure breathing as currently used for aerosol delivery cannot be expected to enhance peripheral deposition of inhaled aerosols in patients with airway obstruction.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 320924     DOI: 10.1164/arrd.1977.115.3.397

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

Review 1.  Aerosol deposition in health and disease.

Authors:  Chantal Darquenne
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2012-06       Impact factor: 2.849

2.  Improving the lung delivery of nasally administered aerosols during noninvasive ventilation-an application of enhanced condensational growth (ECG).

Authors:  P Worth Longest; Geng Tian; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2011-03-16       Impact factor: 2.849

3.  Aerosol salbutamol administration by IPPB: lowest effective dose.

Authors:  R E Ruffin; G Obminski; M T Newhouse
Journal:  Thorax       Date:  1978-12       Impact factor: 9.139

4.  Aerosol bronchodilators and hand-lung dyscoordination.

Authors:  P W Munt
Journal:  Can Med Assoc J       Date:  1979-04-07       Impact factor: 8.262

5.  Evaluation of jet nebulisers for use with gentamicin solution.

Authors:  S P Newman; P G Pellow; M M Clay; S W Clarke
Journal:  Thorax       Date:  1985-09       Impact factor: 9.139

6.  Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality.

Authors:  A J Williams; M S Baghat; D E Stableforth; R M Cayton; P M Shenoi; C Skinner
Journal:  Thorax       Date:  1983-11       Impact factor: 9.139

7.  Abdominal tuberculosis: observations in three cases.

Authors:  R J Smith
Journal:  J Natl Med Assoc       Date:  1978-02       Impact factor: 1.798

Review 8.  Inhaled chemotherapy in lung cancer: future concept of nanomedicine.

Authors:  Paul Zarogoulidis; Ekaterini Chatzaki; Konstantinos Porpodis; Kalliopi Domvri; Wolfgang Hohenforst-Schmidt; Eugene P Goldberg; Nikos Karamanos; Konstantinos Zarogoulidis
Journal:  Int J Nanomedicine       Date:  2012-03-22

Review 9.  Vectors for inhaled gene therapy in lung cancer. Application for nano oncology and safety of bio nanotechnology.

Authors:  Paul Zarogouldis; Nikos K Karamanos; Konstantinos Porpodis; Kalliopi Domvri; Haidong Huang; Wolfgang Hohenforst-Schimdt; Eugene P Goldberg; Konstantinos Zarogoulidis
Journal:  Int J Mol Sci       Date:  2012-08-29       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.